Intel and other venture capitalists seem to like the genomics business too. Personalized medicine holds the key to many areas of Pharmacogenomics and where healthcare is headed. Genomic sequencing stands to unlock many areas of information that will lead us to which drugs and combinations there of will be the one prescribed. Video and more information here about how it will impact medicine as we know it today. BD
A BUNCH of fad-wadded companies is to bung $100 million at a start-up that aims to be able to deliver individuals' DNA sequence a genome in a matter of minutes.
The firm is Pacific Biosciences of California Inc. and according to
the Wall St Journal, the investors include include Intel Capital, Deerfield Capital Management LLC, T. Rowe Price Group, Morgan Stanley, FMR LLC, Alliance Bernstein Holding LP, Maverick Capital Ltd., Redmile Group, Alloy Ventures; DAG Ventures; Teachers' Private Capital; Kleiner Perkins Caufield & Byers; and Mohr Davidow Ventures.
Technorati Tags: Intel,Pharmacogenomics,Investors,DNA,Genomics,Venture Capitolists,Personalized Medicine
0 comments :
Post a Comment